Elevance Health, Inc. (0HG8.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 78.69B |
| Enterprise Value | 101.91B |
| P/E Ratio | 16.79 |
| PEG Ratio | -1.93 |
| Price/Sales Ratio | 0.43 |
| Price/Book Ratio | 1.98 |
| Enterprise/Revenue | 0.54 |
| Enterprise/EBITDA | 12.1 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.03 |
| Operating Margin | 0.04 |
| Return On Assets | 0.04 |
| Return On Equity | 0.12 |
| Revenue | 199.13B |
| Revenue/Share | 908.91 |
| Gross Profit | 50.9B |
| EBITDA | 9.66B |
| Net Income | 5.66B |
| Diluted EPS | 25.21 |
| Total Cash | 9.66B |
| Total Cash/Share | 161.28 |
| Total Debt | 31.84B |
| Total Debt/Equity | 0.73 |
| Current Ratio | 1.48 |
| Book Value Per Share | 199.74 |
| 52-Week Change | 6.21 |
| 52-Week High | 516.42 |
| 52-Week Low | 376.88 |
| Moving Average 50 Days | 493.4 |
| Moving Average 200 Days | 466.52 |
| Average Volume | 8,372 |
| Shares Outstanding | 217.16M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 6.86 |
| Trailing Annual Dividend Yield | 1.74 |
| Payout Ratio | 0.29 |
| Last Split Factor | N/A |
| Last Split Date | N/A |